GustavoSchvartsmanMD

Physician

Dr. Schvartsman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

PubMed

Safety and efficacy of topical testosterone in breast cancer patients receiving ovarian suppression and aromatase inhibitor therapy.
Patrícia Taranto, Diogo de Brito Sales, Fernando Cotait Maluf, Rafael Aliosha Kaliks Guendelmann, Luciano de Melo Pompei
Breast Cancer Research. 2024-09-16
22 citations
Association between weight gain during adjuvant chemotherapy for early-stage breast cancer and survival outcomes.
Gustavo Schvartsman, Angelica M. Gutierrez-Barrera, Juhee Song, Naoto T. Ueno, Susan K. Peterson
Cancer Medicine. 2017-10-10
173 citations
Response rates to single-agent chemotherapy after exposure to immune checkpoint inhibitors in advanced non-small cell lung cancer.
Gustavo Schvartsman, S. Andrew Peng, Giorgios Bis, J. Jack Lee, Marcelo F. Benveniste
Lung Cancer. 2017-10-01

Lectures

Outcomes of metastatic melanoma (MM) patients (pts) after discontinuation of anti-Programmed-Death 1 (PD1) therapy without disease progression.
2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018
A phase II study of study of bevacizumab (BEV) in combination with atezolizumab (ATEZO) in pts (pts) with untreated melanoma brain metastases (BEAT-MBM).
2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018